Connaught licenses tuberculosis and meningitis vaccines from ID Vaccine and North American Vaccine.
Executive Summary
CONNAUGHT PAYS $4.5 MIL. TO LICENSE IDV TUBERCULOSIS VACCINE, Pasteur Merieux-Connaught and ID Vaccine Corp. announced Oct. 2. "IDV will receive an upfront licensing fee, development support payments and an equity investment totaling $4.5 mil." in exchange for exclusive worldwide rights to the firm's TB subunit vaccine technology, the companies said. IDV also will receive "substantial" milestone payments and royalties on product sales.